Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial
Authors
Zhangfa Song (ORCID: https://orcid.org/0000-0001-6301-1813)
Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial
Zhangfa Song, Xuefeng Huang, Jinlin Du, Benxing Gu et al.
Citations
2 citations
Journal
BMC Cancer
Topics
Colorectal Cancer Surgical Treatments
Field-Weighted Citation Impact (FWCI)
0.57
article
Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial
Zhangfa Song, Xuefeng Huang, Jinlin Du, Benxing Gu, Huogang Wang, Engeng Chen, Xia Zhang, Weifeng Lao, Shubo Ding, Min Chen, Jianping Wang, Li Chen, Xiaowei Wang, Xiaonan Sun, Cheng Cai
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 24(1)
Institutions
Sir Run Run Shaw Hospital (CN), Integrated Chinese Medicine (China) (HK), Blood Center of Zhejiang Province (CN), Zhejiang University (CN)
Funders
BeiGene, National Natural Science Foundation of China, Zhejiang University